ArticleCureus2026
Correlation of French Federation of Cancer Centres Sarcoma Group (FNCLCC) Grade With Ki-67 Proliferation Index in Malignant Soft Tissue Sarcomas.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundSoft tissue sarcomas are rare malignant tumours comprising diverse histological subtypes with variable biological behaviour. Histological grading using the French Federation of Cancer Centres Sarcoma Group (FNCLCC) system is widely applied for prognostic stratification. Immunohistochemical advances have introduced proliferative markers such as Ki-67 as potential adjuncts to conventional grading.
objectiveThis study aimed to determine the correlation between the Ki-67 proliferation index and histological grade of soft tissue sarcomas using the FNCLCC grading system.
methodsThis retrospective observational study included 49 histologically confirmed malignant soft tissue sarcomas evaluated at a tertiary care centre over a one-year period. Eligible incisional and excisional biopsy specimens were assessed histopathologically and graded using the FNCLCC grading system. Ki-67 immunohistochemistry was performed, and the proliferation index was categorised as low, intermediate, or high. The association between FNCLCC grade and Ki-67 proliferation index was analysed using the chi-square test, with p < 0.05 considered statistically significant.
resultsThe mean age was 30.6 years with male predominance (male: female = 1.7:1). The lower extremity was the most common site, and Ewing's sarcoma was the predominant subtype (22.4%). Tumours were classified as Grade 1 (14.3%), Grade 2 (42.9%), and Grade 3 (42.9%). A significant association was observed between FNCLCC grade and Ki-67 proliferation index (p < 0.001).
conclusionThe Ki-67 proliferation index showed a significant correlation with FNCLCC histological grade in malignant soft tissue sarcomas and may be considered an adjunctive histopathological marker of proliferative activity. However, larger prospective studies with subtype-stratified analysis and clinical outcome correlation are necessary to determine its independent prognostic relevance and practical applicability.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.